WTR Biotech Spotlight
WTR Biotech Spotlight is a biweekly conversation with biotech executives, medical experts, and investors on recent clinical data or industry-driving events in biotech.
WTR Biotech Spotlight
OS Therapies CEO Paul Romness and CBO Gerald Commisiong Discuss Recent OST-HER2 Phase 2b Data and Next Steps
•
Joe Brunetto
•
Season 1
•
Episode 2
CEO Paul Romness and CBO Gerald Commisiong of OS Therapies join us on our WTR Biotech Spotlight podcast to talk about the OST-HER2 Phase 2b data in recurrent, liver metastatic osteosarcoma and what it could mean for patients with this aggressive cancer. We discuss the plan to approach the FDA and their confidence in a potential accelerated filing. Listen to learn more about OS Therapies and its cancer immunotherapy.